Cardiac mortality in limited-stage small cell lung cancer.
CONCLUSIONS: Although causation between radiotherapy and CSM in LS-SCLC cannot be stated based on these data, we encourage clinical attentiveness to cardiac-sparing radiotherapy for LS-SCLC, along with further investigation evaluating dosimetric correlates for cardiotoxicity.
PMID: 29934110 [PubMed - as supplied by publisher]
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - Category: Radiology Authors: Verma V, Fakhreddine MH, Haque W, Butler EB, Teh BS, Simone CB Tags: Radiother Oncol Source Type: research
More News: Cancer | Cancer & Oncology | Cardiology | Databases & Libraries | Epidemiology | Heart | Lung Cancer | Non-Small Cell Lung Cancer | Radiology | Small Cell Lung Cancer | Statistics | Toxicology